Australia, March 24 -- Contera Pharma A.S, owns the trademark (2611152) for 'SpliceMatrix' till Aug. 29, 2035.
Status: protected:
Registered/protected
Class: 42 [Research and development services in the field of pharmaceuticals and drug discovery; development of processes and methods for medical and veterinary purposes; development of preparations for medical and veterinary purposes; scientific research for medical purposes, namely, screening for the identification of drug candidates; development of precision RNA therapeutics; development of tailored RNA-based corrective interventions to target the root causes of serious diseases; research and development of new medical products for others; development and identification of novel druggable sites for pharmacological intervention using a bioinformatic discovery platform in a wet lab; screening services, bioinformatics services and modelling services to harness natural processes and modulate gene expression through platforms to generate optimized small molecules, antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs); designing and implementing multiplexed high-throughput assays to screen for small molecules that modulate RNA processing using bioinformatic tools.]
Type of Mark: Word
Date of Acceptance: Jan. 15
Registration Advertised: March 23
For further details contact DE FRIES & TUFEKOVIC IP Aps .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2611152.
Disclaimer: Curated by HT Syndication.
